Raymond James Financial Services Advisors Inc. boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 82.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,851 shares of the company’s stock after purchasing an additional 4,009 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Henry Schein were worth $619,000 at the end of the most recent reporting period.
Other institutional investors have also bought and sold shares of the company. FTB Advisors Inc. increased its position in shares of Henry Schein by 100.0% during the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after buying an additional 742 shares during the period. JNBA Financial Advisors boosted its stake in Henry Schein by 100.0% during the third quarter. JNBA Financial Advisors now owns 2,000 shares of the company’s stock worth $164,000 after acquiring an additional 1,000 shares in the last quarter. Westside Investment Management Inc. boosted its stake in Henry Schein by 100.0% during the third quarter. Westside Investment Management Inc. now owns 2,000 shares of the company’s stock worth $160,000 after acquiring an additional 1,000 shares in the last quarter. Advisory Services Network LLC boosted its stake in Henry Schein by 430.1% during the fourth quarter. Advisory Services Network LLC now owns 2,099 shares of the company’s stock worth $147,000 after acquiring an additional 1,703 shares in the last quarter. Finally, Peddock Capital Advisors LLC boosted its stake in Henry Schein by 100.0% during the third quarter. Peddock Capital Advisors LLC now owns 2,194 shares of the company’s stock worth $180,000 after acquiring an additional 1,097 shares in the last quarter. 98.54% of the stock is owned by institutional investors and hedge funds.
Several equities research analysts recently commented on the stock. Leerink Swann raised shares of Henry Schein from a “market perform” rating to an “outperform” rating and set a $75.00 price objective on the stock in a research note on Wednesday. BidaskClub upgraded shares of Henry Schein from a “strong sell” rating to a “sell” rating in a research report on Tuesday, March 27th. Barclays assumed coverage on shares of Henry Schein in a research report on Thursday, March 8th. They set an “equal weight” rating and a $71.00 price objective on the stock. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, March 6th. Finally, Bank of America initiated coverage on shares of Henry Schein in a report on Tuesday, February 27th. They set a “neutral” rating and a $76.00 target price for the company. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $82.31.
HSIC stock opened at $66.78 on Friday. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $10,571.49, a P/E ratio of 18.55, a P/E/G ratio of 1.68 and a beta of 1.05. Henry Schein, Inc. has a 12 month low of $62.56 and a 12 month high of $93.50.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 20th. The company reported $0.97 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.97. The firm had revenue of $3.32 billion for the quarter, compared to the consensus estimate of $3.30 billion. Henry Schein had a net margin of 3.26% and a return on equity of 19.70%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.94 EPS. equities research analysts expect that Henry Schein, Inc. will post 4.09 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/04/07/henry-schein-inc-hsic-stake-increased-by-raymond-james-financial-services-advisors-inc.html.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.